A utilização de fitoterápicos no tratamento da obesidade / Phytoterapic medicines for obesity treatment

A obesidade é considerada um dos maiores problemas de saúde pública no mundo. É um fator que predispõe outras enfermidades e está relacionada ao aumento da taxa de morbidade e mortalidade. Para o tratamento da obesidade são empregados vários métodos, dentre eles o uso da fitoterapia. O presente estudo teve como objetivo avaliar as evidências científicas sobre a utilização do Phaseolus vulgaris, Cynara scolymus e Camelia sinensis no tratamento da obesidade. Trata-se de uma revisão narrativa da literatura, desenvolvida por meio de levantamento bibliográfico de artigos científicos que relacionavam os fitoterápicos com a obesidade, e publicados nos últimos 10 anos. Foi possível observar que estes fitoterápicos podem ser alternativas para tratamento da obesidade. O Phaseolus vulgaris parece proporcionar importante redução de peso devido à redução da absorção dos carboidratos. A Cynara scolymus possui frutooligossacarideos e a inulina, que alteram o trânsito intestinal e ocasionam uma rápida eliminação do bolo fecal, e, consequentemente, reduz a absorção dos lipídeos que, em excesso, contribuem para a obesidade. A Camelia sinensis aumenta a termogênese e a oxidação lipídica, o que promove gasto energético e o emagrecimento. O tratamento da obesidade pode abranger diferentes alternativas terapêuticas, ressaltando sempre a importância da utilização de fitoterápicos indicados apenas por profissionais habilitados, a fim de se alcançar resultados desejáveis e evitar efeitos adversos

Obesity is considered one of the biggest public health problems in the world. It is a factor that predisposes other diseases and it is related to the increase of the rate of morbidity and mortality. Several methods are employed to treat obesity, among them the use of herbal medicine. The present study aimed to evaluate the scientific evidence on the use of Phaseolus vulgaris, Cynara scolymus and Camelia sinensis in the treatment of obesity. This is a narrative review of the literature, developed through a bibliographical survey of scientific articles that related phytotherapeutics to obesity, and published in the last 10 years. It was possible to observe that these phytotherapics may be alternatives for the treatment of obesity. Phaseolus vulgaris appears to provide significant weight reduction due to reduced absorption of carbohydrates. Cynara scolymus has fructooligosaccharides and inulin, which alter intestinal transit and cause a rapid elimination of faecal cake, and consequently reduces the absorption of lipids that in excess contribute to obesity. Camelia sinensis increases thermogenesis and lipid oxidation, which promotes energy expenditure and weight loss. The treatment of obesity can cover different therapeutic alternatives, always emphasizing the importance of the use of phytotherapics indicated only by qualified professionals, in order to achieve desirable results and avoid adverse effects

Genotoxicity and 28-day oral toxicity studies of a functional food mixture containing maltodextrin, white kidney bean extract, mulberry leaf extract, and niacin-bound chromium complex.

Steady-fiber granule (SFG) is a functional food mixture that is composed of four major ingredients, resistant maltodextrin, white kidney bean (Phaseolus vulgaris) extract, mulberry leaf (Morus alba L.) extract, and niacin-bound chromium complex. This study focused on determining the safety of SFG. Genotoxicity and 28-day oral toxicity were evaluated. SFG did not induce mutagenicity in the bacterial reverse mutation assay using five Salmonella typhimurium strains (TA98, TA100, TA102, TA1535, and TA1537) in the presence or absence of metabolic activation (S9 system). SFG also did not induce clastogenic effects in Chinese hamster ovary cells with or without S9 treatment. Similarly, SFG did not induce genotoxicity in a micronucleus test conducted with mice. A dose-dependent 28-day oral toxicity assessment of SFG for rats revealed no significant effects on mortality, body weight, selected organ weights, and behavior. Evaluations of hematology, clinical biochemistry, and histopathology showed no adverse effects in rats treated with SFG. These results suggest that SFG has no significant mutagenic or toxic properties, and the no observed adverse effect level of SFG was defined as at least 5000 mg/kg/day orally for 28 days for male and female rats.

In Rwandese Women with Low Iron Status, Iron Absorption from Low-Phytic Acid Beans and Biofortified Beans Is Comparable, but Low-Phytic Acid Beans Cause Adverse Gastrointestinal Symptoms.

BACKGROUND: Phytic acid (PA) is a major inhibitor of iron bioavailability from beans, and high PA concentrations might limit the positive effect of biofortified beans (BBs) on iron status. Low-phytic acid (lpa) bean varieties could increase iron bioavailability. OBJECTIVE: We set out to test whether lpa beans provide more bioavailable iron than a BB variety when served as part of a composite meal in a bean-consuming population with low iron status. METHODS: Dietary iron absorption from lpa, iron-biofortified, and control beans (CBs) (regular iron and PA concentrations) was compared in 25 nonpregnant young women with low iron status with the use of a multiple-meal crossover design. Iron absorption was measured with stable iron isotopes. RESULTS: PA concentration in lpa beans was ∼10% of BBs and CBs, and iron concentration in BBs was ∼2- and 1.5-fold compared with CBs and lpa beans, respectively. Fractional iron absorption from lpa beans [8.6% (95% CI: 4.8%, 15.5%)], BBs [7.3% (95% CI: 4.0%, 13.4%)], and CBs [8.0% (95% CI: 4.4%, 14.6%)] did not significantly differ. The total amount of iron absorbed from lpa beans and BBs was 421 µg (95% CI: 234, 756 µg) and 431 µg (95% CI: 237, 786 µg), respectively, and did not significantly differ, but was >50% higher (P < 0.005) than from CBs (278 µg; 95% CI: 150, 499 µg). In our trial, the lpa beans were hard to cook, and their consumption caused transient adverse digestive side effects in ∼95% of participants. Gel electrophoresis analysis showed phytohemagglutinin L (PHA-L) residues in cooked lpa beans. CONCLUSION: BBs and lpa beans provided more bioavailable iron than control beans and could reduce dietary iron deficiency. Digestive side effects of lpa beans were likely caused by PHA-L, but it is unclear to what extent the associated digestive problems reduced iron bioavailability. This trial was registered at clinicaltrials.gov as NCT02215278.

Cooked navy and black bean diets improve biomarkers of colon health and reduce inflammation during colitis.

Common beans contain non-digestible fermentable components (SCFA precursors) and phenolic compounds (phenolic acids, flavonoids and anthocyanins) with demonstrated antioxidant and anti-inflammatory potential. The objective of the present study was to assess the in vivo effect of cooked whole-bean flours, with differing phenolic compound levels and profiles, in a mouse model of acute colitis. C57BL/6 mice were fed a 20 % navy bean or black bean flour-containing diet or an isoenergetic basal diet (BD) for 2 weeks before the induction of experimental colitis via 7 d dextran sodium sulphate (DSS, 2 % (w/v) in the drinking-water) exposure. Compared with the BD, both bean diets increased caecal SCFA and faecal phenolic compound concentrations (P< 0·05), which coincided with both beneficial and adverse effects on colonic and systemic inflammation. On the one hand, bean diets reduced mRNA expression of colonic inflammatory cytokines (IL-6, IL-9, IFN-γ and IL-17A) and increased anti-inflammatory IL-10 (P< 0·05), while systemically reduced circulating cytokines (IL-1ß, TNFα, IFNγ, and IL-17A, P< 0·05) and DSS-induced oxidative stress. On the other hand, bean diets enhanced DSS-induced colonic damage as indicated by an increased histological injury score and apoptosis (cleaved caspase-3 and FasL mRNA expression) (P< 0·05). In conclusion, bean-containing diets exerted both beneficial and adverse effects during experimental colitis by reducing inflammatory biomarkers both locally and systemically while aggravating colonic mucosal damage. Further research is required to understand the mechanisms through which beans exert their effects on colonic inflammation and the impact on colitis severity in human subjects.

Lowering the glycemic index of white bread using a white bean extract.

BACKGROUND: Phase 2((R)) is a dietary supplement derived from the common white kidney bean (Phaseolus vulgaris). Phase 2 has been shown to inhibit alpha-amylase, the complex carbohydrate digesting enzyme, in vitro. The inhibition of alpha-amylase may result in the lowering of the effective Glycemic Index (GI) of certain foods. The objective of this study was to determine whether the addition of Phase 2 would lower the GI of a commercially available high glycemic food (white bread). METHODS: An open-label 6-arm crossover study was conducted with 13 randomized subjects. Standardized GI testing was performed on white bread with and without the addition of Phase 2 in capsule and powder form, each in dosages of 1500 mg, 2000 mg, and 3000 mg. Statistical analysis was performed by one-way ANOVA of all seven treatment groups using unadjusted multiple comparisons (t tests) to the white bread control. RESULTS: For the capsule formulation, the 1500 mg dose had no effect on the GI and the 2000 mg and 3000 mg capsule doses caused insignificant reductions in GI. For the powder, the 1500 mg and 2000 mg doses caused insignificant reductions in the GI, and the 3000 mg dose had a significant effect (-20.23 or 34.11%, p = 0.023) CONCLUSION: Phase 2 white bean extract appears to be a novel and potentially effective method for reducing the GI of existing foods without modifying their ingredient profile. TRIAL REGISTRATION: Trial Registration: ISRCTN50347345.

Angioedema induced by inhalation of vapours from cooked white bean in a child.

BACKGROUND: There are few references of allergic reaction to beans in childhood. We report the case of a seven years old boy who suffered from angioedema associated to inhalation of vapours from cooked white bean. METHODS: skin prick tests (SPT) were performed by prick-by-prick with cooked white bean and legumes. It was also determined total IgE and specific IgE antibodies to bean and legumes with the use of the CAP enzymo-immunoassay. Subsequently, a oral challenge test was carried out with white bean. RESULTS: The prick-by-prick with white bean was positive in our case, and negative in ten controls patients. Specific IgE in patient serum, assayed by CAP was positive for white bean and green bean. The patient developed angioedema after ingestion cooked white bean. CONCLUSION: we demonstrated a type I hypersensitivity to white bean in a seven years old child by SPT, specific IgE antibodies and challenge test.